BPC-157
Body Protection Compound-157
A synthetic peptide derived from a protective protein found in gastric juice that may accelerate healing of various tissues including tendons, muscles, nerves, and the digestive tract.
Administration Routes
Half-Life
4-6 hours
About BPC-157
BPC-157 (Body Protection Compound-157) is a synthetic peptide composed of 15 amino acids that was isolated from human gastric juice. It has been studied for its potential healing properties across multiple tissue types. Research suggests it may promote angiogenesis (formation of new blood vessels), which is crucial for tissue repair. It has shown promise in studies for healing tendons, muscles, nerves, and organs, particularly in the digestive system.
Potential Benefits
May significantly speed up recovery from injuries to tendons, ligaments, and muscles.
Shows potential in healing inflammatory bowel conditions and protecting the gut lining.
Demonstrates anti-inflammatory properties that may help reduce pain and swelling.
Some research suggests potential benefits for nerve regeneration and brain injury recovery.
Dosage Information
Recommended Dosage
250-500 mcg
Frequency
1-2 times daily
Typical Cycle
4-8 weeks on, 2-4 weeks off
Notes
Lower doses may be effective for maintenance, while higher doses are often used for acute injuries.
Dosage information is based on anecdotal reports and limited research. Always consult with a healthcare professional before using peptides.
Potential Side Effects
| Effect | Severity | Frequency |
|---|---|---|
| Nausea | Mild | Uncommon |
| Dizziness | Mild | Rare |
| Injection site reactions | Mild | Common |
Long-term safety data for peptides is limited. Side effects may vary between individuals, and unknown risks may exist.
Expert Opinions
BPC-157 shows remarkable promise for tissue healing. While more human clinical trials are needed, the existing research and clinical observations suggest significant potential for injury recovery and inflammatory conditions.
In my practice, I've observed BPC-157 to be particularly effective for tendon and ligament injuries when used as part of a comprehensive treatment approach. The safety profile appears favorable based on available data.
Frequently Asked Questions
BPC-157 exists in a regulatory gray area in many countries. It is not approved by the FDA for human use but is often sold as a research chemical. It is not a controlled substance in most countries, but regulations vary. Always check your local laws before purchasing.
No, studies suggest that BPC-157 has systemic effects even when injected subcutaneously away from the injury site. However, some practitioners believe that local injection may provide additional benefits for certain injuries.
Yes, BPC-157 is stable in gastric acid and can be effective when taken orally, particularly for digestive system issues. However, for musculoskeletal injuries, subcutaneous injection is often preferred for maximum efficacy.
Many users report noticing initial improvements within 1-2 weeks, with more significant results appearing after 3-4 weeks of consistent use. However, response times vary based on the condition being treated and individual factors.
Category
Healing Peptides
Research Level
Moderate
Administration
Oral, Subcutaneous, Topical
Typical Dosage
250-500 mcg
Half-Life
4-6 hours
Peptides like BPC-157 are typically sold for research purposes only and are not approved by the FDA for human consumption. Limited human clinical data exists on safety and efficacy.
This information is provided for educational purposes only and is not medical advice.